CandaceLynnHaddoxMD

Oncology • Boston, MA

Sarcoma

Clinical Investigator, Sarcoma Center, Dana-Farber Cancer Institute

Join to view full profile

Dr. Haddox is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Haddox's full profile

Already have an account?

Office
450 Brookline Ave
Boston, MA 02215
Phone+1 617-632-5204

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2018 - 2021
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2015 - 2018
University of South Florida College of MedicineClass of 2015

Certifications & Licensure

NH State Medical License 2022 - 2026
RI State Medical License 2022 - 2026
MA State Medical License 2021 - 2025
ME State Medical License 2022 - 2025
VT State Medical License 2022 - 2024
NC State Medical License 2018 - 2021
MN State Medical License 2016 - 2018
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

46 citations
Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis
Candace L. Haddox, Abhishek A. Mangaonkar, Dong Chen, Min Shi, Rong He
Blood Cancer Journal. 2017-09-15
22 citations
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer.
Lars D Engstrom, Ruth Aranda, Laura Waters, Krystal Moya, Vickie Bowcut
Cancer Discovery. 2023-11-01
212 citations
Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years
Narjust Duma, Jesus Vera Aguilera, Jonas Paludo, Candace L. Haddox, Miguel Gonzalez Velez
Journal of Oncology Practice. 2018-01-01

Journal Articles

Submandibular parasympathetic gangliogenesis requires sprouty-dependent wnt signals from epithelial progenitors.
Knosp WM, Knox SM, Lombaert IM, Haddox CL, Patel VN, Hoffman MP., Developmental Cell, 3/23/2015